Cancer-associated thrombosis: the when, how and why
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognised both for physicians that deal with venous thromboembolism (VTE) and for oncologists. It is currently estimated that the annual incidence of VTE in patients with cancer is 0.5% compared to 0.1% in the general population. Active cancer accounts for 20% of the overall incidence of VTE. Of note, VTE is the second most prevalent cause of death in cancer, second only to the progression of the disease, and cancer is the most prevalent cause of deaths in VTE patients. Nevertheless, CAT presents several peculiarities that distinguish it from other VTE, both in pathophysiology mechanisms, risk factors and especially in treatment, which need to be considered. CAT data will be reviewed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Development and validation of a predictive model for chemotherapy-associated thrombosis
Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., & Francis, C. W. (2008) · Blood · doi:10.1182/blood-2007-10-116327 · Cited by 2,217
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Raskob, G. E., van Es, N., Verhamme, P., Carrier, M., Di Nisio, M., Garcia, D., Grosso, M. A., Kakkar, A. K., Kovacs, M. J., Mercuri, M. F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711948 · Cited by 1,633
Lyman, G. H., Bohlke, K., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7351 · Cited by 1,371
Young, A. M., Marshall, A., Thirlwall, J., Chapman, O., Lokare, A., Hill, C., Hale, D., Dunn, J. A., Lyman, G. H., Hutchinson, C., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8034 · Cited by 1,348
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
Hooper, C., Laurence, I., Harvey, J., Morley, A., Darby, M., Edey, A., & Maskell, N. (2014) · Respiration · doi:10.1159/000347003 · Cited by 1,184
The epidemiology of venous thromboembolism
Heit, J. A., Spencer, F. A., & White, R. H. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1311-6 · Cited by 1,093
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Carrier, M., Abou-Nassar, K., Mallick, R., Tagalakis, V., Shivakumar, S., Schattner, A., Kuruvilla, P., Hill, D., Spadafora, S., Marquis, K., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814468 · Cited by 852
Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Prediction of venous thromboembolism in cancer patients
Ay, C., Dunkler, D., Marosi, C., Chiriac, A.-L., Vormittag, R., Simanek, R., Quehenberger, P., Zielinski, C., & Pabinger, I. (2010) · Blood · doi:10.1182/blood-2010-02-270116 · Cited by 772
Laporte, S., Mismetti, P., Décousus, H., Uresandi, F., Otero, R., Lobo, J. L., Monreal, M., & the RIETE Investigators (2008) · Circulation · doi:10.1161/circulationaha.107.726232 · Cited by 671
Lee, A. Y. Y., Kamphuisen, P. W., Meyer, G., Bauersachs, R., Janas, M. S., Jarner, M. F., Khorana, A. A., & for the CATCH Investigators (2015) · JAMA · doi:10.1001/jama.2015.9243 · Cited by 614
Agnelli, G., Gussoni, G., Bianchini, C., Verso, M., Mandalà, M., Cavanna, L., Barni, S., Labianca, R., Buzzi, F., Scambia, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70232-3 · Cited by 598
Incidence of Venous Thromboembolism in Patients Hospitalized with Cancer
Stein, P. D., Beemath, A., Meyers, F. A., Skaf, E., Sanchez, J., & Olson, R. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.058 · Cited by 566
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Agnelli, G., George, D. J., Kakkar, A. K., Fisher, W., Lassen, M. R., Mismetti, P., Mouret, P., Chaudhari, U., Lawson, F., & Turpie, A. G. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108898 · Cited by 531
Walker, A. J., Card, T. R., West, J., Crooks, C., & Grainge, M. J. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.021 · Cited by 512
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
Mandalà, M., Falanga, A., & Roila, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr392 · Cited by 512
Khorana, A. A., Noble, S., Lee, A. Y. Y., Soff, G., Meyer, G., O'Connell, C., & Carrier, M. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14219 · Cited by 442
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Akl, E. A., Kahale, L. A., Barba, M., Neumann, I., Labedi, N., Terrenato, I., Sperati, F., Muti, P., & Schünemann, H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006650.pub4 · Cited by 428
Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism
Schulman, S., & Lindmarker, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422604 · Cited by 326
Carrier, M., Le Gal, G., Wells, P. S., Fergusson, D., Ramsay, T., & Rodger, M. A. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-5-200809020-00007 · Cited by 302
Screening for Occult Cancer in Unprovoked Venous Thromboembolism
Carrier, M., Lazo-Langner, A., Shivakumar, S., Tagalakis, V., Zarychanski, R., Solymoss, S., Routhier, N., Douketis, J., Danovitch, K., Lee, A. Y., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506623 · Cited by 300
Direct Oral Anticoagulants in Patients With VTE and Cancer
Vedovati, M. C., Germini, F., Agnelli, G., & Becattini, C. (2015) · Chest · doi:10.1378/chest.14-0402 · Cited by 270
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Di Nisio, M., Porreca, E., Ferrante, N., Otten, H.-M., Cuccurullo, F., & Rutjes, A. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008500.pub2 · Cited by 264
Mechanism and management of cancer-associated thrombosis
Mukai, M., & Oka, T. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.02.011 · Cited by 212
Cancer-Associated Thrombosis: An Overview
Elyamany, G., Alzahrani, A. M., & Bukhary, E. (2014) · Clinical Medicine Insights: Oncology · doi:10.4137/cmo.s18991 · Cited by 209
Guideline on aspects of cancer‐related venous thrombosis
Watson, H. G., Keeling, D. M., Laffan, M., Tait, R. C., & Makris, M. (2015) · British Journal of Haematology · doi:10.1111/bjh.13556 · Cited by 182
Trujillo-Santos, J., Nieto, J., Tiberio, G., Piccioli, A., Micco, P., Prandoni, P., & Monreal, M. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-02-0125 · Cited by 172
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism
van Es, N., Gal, G. L., Otten, H.-M., Robin, P., Piccioli, A., Lecumberri, R., Jara‐Palomares, L., Religa, P., Rieu, V., Rondina, M. T., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0868 · Cited by 157
Thrombosis: A major contributor to global disease burden
Raskob, G. E., & ISTH Steering Committee for World Thrombosis Day (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-08-0671 · Cited by 155
Agnelli, G., Becattini, C., Bauersachs, R. M., Brenner, B., Campanini, M., Cohen, A. T., Connors, J. M., Fontanella, A., Gussoni, G., Huisman, M. V., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1668523 · Cited by 152
Epidemiology of venous thromboembolism in the Framingham Heart Study
Puurunen, M. K., Gona, P. N., Larson, M. G., Murabito, J. M., Magnani, J. W., & O’Donnell, C. J. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.06.033 · Cited by 148
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Nisio, M. D., Porreca, E., Candeloro, M., Tursi, M. D., Russi, I., & Rutjes, A. W. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008500.pub4 · Cited by 147
Arterial and Venous Thrombosis in Cancer Patients
Blann, A. D., & Dunmore, S. (2011) · Cardiology Research and Practice · doi:10.4061/2011/394740 · Cited by 133
The JAK2 V617F somatic mutation, mortality and cancer risk in the general population
Nielsen, C., Birgens, H. S., Nordestgaard, B. G., Kjaer, L., & Bojesen, S. E. (2011) · Haematologica · doi:10.3324/haematol.2010.033191 · Cited by 132
Napolitano, M., Saccullo, G., Malato, A., Sprini, D., Ageno, W., Imberti, D., Mascheroni, D., Bucherini, E., Gallucci, P., D’Alessio, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.7433 · Cited by 113
Ades, S., Kumar, S., Alam, M., Goodwin, A., Weckstein, D. J., Dugan, M., Ashikaga, T., Evans, M., Verschraegen, C. F., & Holmes, C. E. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12910 · Cited by 94
Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH
Delluc, A., Antic, D. A., Lecumberri, R., Ay, C., Meyer, G., & Carrier, M. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13791 · Cited by 94
Sun, J., Kim, T., Lee, J., Park, Y. H., Ahn, J. S., Kim, H., Kwon, O. J., Lee, K. S., Park, K., & Ahn, M. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.015 · Cited by 93
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE
Jara‐Palomares, L., Otero, R., Jiménez, D., Carrier, M., Tzoran, I., Brenner, B., Vila, M. M., Praena‐Fernández, J. M., Grandone, E., Monréal, M., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.10.025 · Cited by 80
Risk stratification strategies for cancer-associated thrombosis: an update
Khorana, A. A., & McCrae, K. R. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50006-0 · Cited by 79
Epidemiology, risk and outcomes of venous thromboembolism in cancer
Russo, L., & Falanga, A. (2011) · Hämostaseologie · doi:10.5482/ha-1170 · Cited by 78
Management of incidental pulmonary embolism
Klok, F. A., & Huisman, M. V. (2017) · European Respiratory Journal · doi:10.1183/13993003.00275-2017 · Cited by 73
New anticoagulants for the treatment of venous thromboembolism
Fernandes, C. J. C. D. S., Alves, J. L., Gavilanes, F., Prada, L. F., Morinaga, L. T. K., & Souza, R. (2016) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562016042020068 · Cited by 70
Self-citationJAK2 mutations across a spectrum of venous thrombosis cases.
Shetty, S., Kulkarni, B., Pai, N., Mukundan, P., Kasatkar, P., & Ghosh, K. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcp7vo4haizyatp · Cited by 68
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
Hakoum, M. B., Kahale, L. A., Tsolakian, I. G., Matar, C. F., Yosuico, V. E. D., Terrenato, I., Sperati, F., Barba, M., Schünemann, H. J., & Akl, E. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006649.pub7 · Cited by 65
Gade, I. L., Brækkan, S. K., Næss, I. A., Hansen, J., Cannegieter, S. C., Overvad, K., Jensvoll, H., Hammerstrøm, J., Blix, K., Tjønneland, A. M., et al. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13752 · Cited by 57
Pignataro, B. S., Nishinari, K., Cavalcante, R. N., Centofanti, G., Yazbek, G., Krutman, M., Bomfim, G. A. Z., Fonseca, I. Y. I., Teivelis, M. P., Wolosker, N., et al. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616677800 · Cited by 29
Coyle, K., Carrier, M., Lazo‐Langner, A., Shivakumar, S., Zarychanski, R., Tagalakis, V., Solymoss, S., Routhier, N., Douketis, J. D., & Coyle, D. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.01.007 · Cited by 27
Thromboembolism preceding cancer: A correlation study
Saba, H. I., Khalil, F. K., Morelli, G. A., & Foulis, P. (2003) · American Journal of Hematology · doi:10.1002/ajh.10269 · Cited by 24
Reperfusion in acute pulmonary thromboembolism
Fernandes, C. J. C. D. S., Jardim, C., Alves, J. L., Gavilanes, F., Morinaga, L. T. K., & Souza, R. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000204 · Cited by 14
Self-citationRivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis?
Xavier, F. D., Hoff, P. M., Braghiroli, M. I., et al. (2016) · Journal of Global Oncology · doi:10.1200/jgo.2015.002527 · Cited by 12
Primary prophylaxis of VTE in cancer outpatients
Imberti, D., & Benedetti, R. (2016) · Thrombosis Research · doi:10.1016/s0049-3848(16)30108-6 · Cited by 7
Cited by
Metelli, A., Wu, B. X., Riesenberg, B., Guglietta, S., Huck, J. D., Mills, C., Li, A., Rachidi, S., Krieg, C., Rubinstein, M. P., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay4860 · Cited by 139
Metadata
- Authors
- Fernandes, C. J., Morinaga, L. T. K., Alves, J. L., Castro, M. A., Calderaro, D., Jardim, C. V. P., & Souza, R.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-03-27
- Volume
- 28
- Issue
- 151
- Pages
- 180119
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2924354627
- Cited by
- 326
- References
- 57
- FWCI
- 18.01
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.